Investigation into the hepatotoxicity of the novel anti-cancer drug Ecteinascidin-743 (ET-743)

Investigation into the hepatotoxicity of the novel anti-cancer drug Ecteinascidin-743 (ET-743)

Ecteinascidin-743 (ET-743) is a novel marine-derived anti-cancer drug with demonstrated anti-tumour activity in clinical trials against sarcoma, breast and ovarian carcinoma. Reversible transaminitis and subclinical cholangitis have frequently been described in patients who receive ET-743. To facili...

Full description

Bibliographic Details
Main Author:	Donald, Sarah
Published:	University of Leicester 2003
Subjects:	616.99
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.490756

Similar Items

Investigating the role of CAR and PXR in the regulation of cytochrome P450s and other drug metabolising enzymes by anti-cancer drugs using novel humanised mouse models
by: Fraser, Emily Anne
Published: (2013)

The development of anti-cancer drug delivery systems
by: Zong, Jingyi
Published: (2016)

Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells
by: Patrick J. Grohar, et al.
Published: (2011-02-01)

Modelling and investigation of drug and immune therapies for cancer
by: Hamam, Haneen
Published: (2017)

Defining the role of microRNA-122 in the early detection of chemotherapy-induced hepatotoxicity in the neo-adjuvant treatment of advanced colorectal cancer
by: McWhirter, Derek
Published: (2014)

Bioresponsive polymer-phospholipase A2 conjugates as novel anti-cancer agents
by: Ferguson, Elaine Lesley
Published: (2008)

Determining the efficacy of novel anti-androgens in models of castrate resistant prostate cancer
by: O'Neill, Daniel James
Published: (2014)

Investigation into the molecular mechanisms of the anti-apoptotic function of CTCF in breast cancer cells
by: Mendez-Catala, Claudia Fabiola
Published: (2011)

A pre-clinical investigation of the anti-cancer effects of the frankincense constituent AKBA on ovarian cancer cells
by: Al-Salmani, Kamla Khalfan Said
Published: (2017)

Ecteinascidin-743: Evidence of Activity in Advanced, Pretreated Soft Tissue and Bone Sarcoma Patients
by: G. Huygh, et al.
Published: (2006-01-01)

Investigation of cellular and molecular mechanisms involved in targeted drug delivery systems for human cancers
by: Kaur, Davinder
Published: (2002)

Investigation of resolvin E1 as a metabolite of eicosapentaenoic acid with anti-colorectal cancer activity
by: Hutchinson, John Michael
Published: (2016)

Biochemical studies on anti-cancer treatments
by: Abdul-Majied Ibrahim, S.
Published: (1976)

Novel strategies for the identification of biomarkers of non-Hodgkin lymphoma : evidence from the European Prospective Investigation into Cancer (EPIC)
by: Kelly, Rachel
Published: (2013)

Molecular characterisation of childhood craniopharyngioma and identification and testing of novel drug targets
by: Apps, John Richard
Published: (2018)

Ovarian cancer stem-like cells and drug resistance
by: Richardson, Julie
Published: (2014)

Investigation of a potentially novel oncolytic adenovirus
by: Alqahtani, Ali Saeed
Published: (2015)

Mono and dinuclear ruthenium complexes as anti-cancer therapeutic leads
by: Jarman, Paul J.
Published: (2015)

Novel approaches in the management of bladder cancer
by: Greensmith, R. M. D.
Published: (2016)

Screening and identification of kinases involved in drug resistance in bladder cancer
by: Mufti, Uwais Bashir
Published: (2014)

The investigation of novel agents for the therapy of acute myeloid leukaemia
by: Jenkins, Christopher
Published: (2009)

Optimising Reovirus Type 3 Dearing (Reolysin®) as an anti-cancer therapeutic
by: Bolton, Gemma C.
Published: (2016)

Risk factors and novel biomarkers in breast cancer
by: Fourkala, E.-O.
Published: (2011)

Defining novel targets for immunotheraphy of human cancer
by: Nunes, Claudia
Published: (2010)

Novel functions of NF-κB in cancer
by: Leow, Shi Chi
Published: (2012)

The identification and validation of drug targets for prostate cancer using integrated approaches
by: Oloko, Olayinka Azeez
Published: (2014)

Investigating the adverse effects of novel tumour-specific IAP antagonists
by: Hayward, Giles Mortimer
Published: (2017)

Studies on IL-15 mediated anti-tumour immune responses in prostate cancer
by: Sakellariou, Christina Alexandra
Published: (2017)

The roles of microRNAs in the anti-cancer effects of sulforaphane from cruciferous vegetables
by: Dacosta, Christopher
Published: (2017)

Investigation of heterotypic interactions between cancer cells and cancer-associated fibroblasts
by: Derzsi, S. J.
Published: (2015)

Methodological issues in electronic healthcare database studies of drug cancer associations : identification of cancer, and drivers of discrepant results
by: Rañopa, M. E.
Published: (2016)

Identification of effective new drugs combinations exploiting the ability of trabectedin to modulate transcription
by: Uboldi, Sarah
Published: (2017)

Novel therapeutic and diagnostic ultrasound techniques in cancer management
by: Abel, Mark Joshua
Published: (2016)

Novel multifunctional delivery systems for the treatment of prostate cancer
by: Massey, A.
Published: (2014)

The identification of novel biomarkers to guide treatment in endometrial cancer
by: Kularatne, B. Y.
Published: (2017)

Modulation of the anti-angiogenic protein FKBPL : implications for a host of diseases, including cancer
by: Bennett, Rachel
Published: (2015)

An investigation into the role of microRNAs in prostate cancer
by: Lynch, Seodhna M.
Published: (2016)

An investigation into the pathophysiology of breast cancer-related lymphoedema
by: Bains, Salena Raminder Ramanjeet Kaur
Published: (2015)

Biochemical studies on the response of tumours to cytotoxic drugs and hyperthemia, with special reference to human cancer
by: Suzangar, M.
Published: (1972)

Epithelial-to-mesenchymal transition : what is the impact on breast cancer stem cells and drug resistance
by: Mallini, Paraskevi
Published: (2015)